Cercosporin is a potent photosensitizer with a short activation wavelength, primarily used in surface photodynamic therapy (PDT) research, especially in studies aiming to avoid perforation; it acts as a protein kinase C (PKC) inhibitor with an IC50 of 0.6–1.3 μM; it exhibits stronger photodynamic therapy effects in T98G glioblastoma cells compared to U87 or MCF-7 cells; it shows synergistic cytotoxicity with copper in MCF-7 breast carcinoma and T98G glioblastoma cells, but only minimal additive effects in U87 cells.